| ID | 1513 | |
| PMID | 15603887 | |
| Year | 2005 | |
| Sequence | APQIPPNWHIPSIQDA ATPYHPPATPNNMGL | |
| Name | gD 287-317 (group 3) | |
| Length | 31 | |
| N-Terminal Modification | Free | |
| C-Terminal Modification | Free | |
| Linear/ Cyclic | Linear | |
| Chirality | L | |
| Chemical Modification | None | |
| Origin of Peptide | T-cell epitope peptide identified from HSV1-gD | |
| Nature of Peptide/Cargo | not mentioned | |
| Mechanism | T-cell epitope peptide identified from HSV1-gD | |
| Cargo Sequence/Structure | None | |
| Name of cargo | Not applicable | |
| Assay | ELISA, Antibody assay, Peptide specific T-cell assays | |
| Enhancer | PBS (pH 7.3). | |
| Properties of enhancer | Not mentioned | |
| Concentration | 25ul | |
| Incubation time | 21 days | |
| Tissue permeability (value with units) | Gave lower but significant responses (p <0.05) | |
| Tissue Sample | eye | |
| Ex vivo/In vivo/In vitro | in vivo | |
| STRUCTURE |
| |
| SMILES | N[C@H](C(=O)N1[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N2[C@H](C(=O)N3[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N4[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H] (C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C (=O)N[C@H](C(=O)N[C@@H]5[C@H](OCCC5)N[C@H](C(=O)N[C@H](C (=O)N5[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O) NCC(=O)N[C@H](C=O)CC(C)C)CCSC)CC(=O)N)CC(=O)N) CCC5)[C@H](O)C)C)CCC)Cc5[nH]cnc5)Cc5ccc(cc5)O)CCC) [C@H](O)C)C)C)CC(=O)O)CCC(=O)N)[C@H](CC)C)CO)CCC4)[C@H](CC) C)Cc4[nH]cnc4)Cc4c[nH]c5c4cccc5)CC(=O)N)CCC3)CCC2) [C@H](CC)C)CCC(=O)N)CCC1)C | |